Literature DB >> 67200

[The "off-on" phenomenon during treatment of parkinson's disease with levodopa (author's transl)].

J Wajsbort.   

Abstract

The fluctuation in daily performance of Parkinson patients on long-term L-dopa therapy is known as the so called "off-on" phenomenon. Cotzias et al. found that a low protein diet is able to control this phenomenon in patients taking L-dopa alone but not in those receiving a combination of L-dopa and decarboxylase inhibitor. The author's hypothesis was based on the competition between the alimentary aminoacids and L-dopa for transport to the brain ganglia. In our attempt to prove the findings of Cotzias group we tested the influence of a low protein diet on 23 Parkinson patients manifesting the "off-on" phenomenon. All had been pretreated with L-dopa for 5--8 years and taking dopa DI for a minimum of 3 years. The protein intake was limited to 25 g/day (which is less than 0.5 g/kg body weight) for 1--4 months. In 6 cases there was a marked improvment with reduction of the "off-on" effect, and in one it disappeared completely. A distinct improvment of general capability was seen in the other 5 cases, and an objective improvment of the symptoms was noted, except during the "off" period. No response could be observed in the remaining 12 cases. All cases with hyperkinesia showed an augmentation of this symptom during the use of the diet. The diet restriction was not found to be correlated with age, stage, duration of illness or duration of dopa treatment. The possible mechanism of the "off-on" phenomenon and some suggestions to influence it, are presented.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 67200     DOI: 10.1007/BF00312550

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  17 in total

1.  The potentiation of the anti akinetic effect after L-dopa treatment by an inhibitor of MAO-B, Deprenil.

Authors:  W Birkmayer; P Riederer; M B Youdim; W Linauer
Journal:  J Neural Transm       Date:  1975       Impact factor: 3.575

2.  Cyclic AMP in Brain: Role in Synaptic Transmission.

Authors:  J L Marx
Journal:  Science       Date:  1972-12-15       Impact factor: 47.728

3.  Importance of nervous impulse flow for the neuroleptic induced increase in amine turnover in central dopamine neurons.

Authors:  N E Andén; H Corrodi; K Fuxe; U Ungerstedt
Journal:  Eur J Pharmacol       Date:  1971-07       Impact factor: 4.432

4.  Dopamine-sensitive adenyl cyclase: possible role in synaptic transmission.

Authors:  J W Kebabian; P Greengard
Journal:  Science       Date:  1971-12-24       Impact factor: 47.728

5.  Long-term side-effects of levodopa.

Authors:  A Barbeau
Journal:  Lancet       Date:  1971-02-20       Impact factor: 79.321

6.  Modification of Parkinsonism--chronic treatment with L-dopa.

Authors:  G C Cotzias; P S Papavasiliou; R Gellene
Journal:  N Engl J Med       Date:  1969-02-13       Impact factor: 91.245

7.  Apomorphine in Parkinsonian tremor.

Authors:  J Braham; I Sarova-Pinhas; Y Goldhammer
Journal:  Br Med J       Date:  1970-09-26

8.  Effect of chronic amphetamine exposure on stereotyped behavior: implications for pathogenesis of l-dopa-induced dyskinesias.

Authors:  H L Klawans; P Crossett; N Dana
Journal:  Adv Neurol       Date:  1975

9.  Idiopathic parkinsonism treated with bromocriptine.

Authors:  P F Teychenne; P N Leigh; J L Reid; D B Calne; J K Greenacre; A Petrie; A N Bamji
Journal:  Lancet       Date:  1975-09-13       Impact factor: 79.321

10.  Modification of L-dopa therapy of Parkinsonism by alpha-methyldopa hydrazine (MK-486).

Authors:  M D Yahr; R C Duvoisin; M R Mendoza; M J Schear; R E Barrett
Journal:  Trans Am Neurol Assoc       Date:  1971
View more
  7 in total

Review 1.  Effects of therapy for dysphagia in Parkinson's disease: systematic review.

Authors:  Laura W J Baijens; Renée Speyer
Journal:  Dysphagia       Date:  2008-10-18       Impact factor: 3.438

Review 2.  The Effect of Deep Brain Stimulation on Swallowing Function in Parkinson's Disease: A Narrative Review.

Authors:  Min Cheol Chang; Jin-Sung Park; Byung Joo Lee; Donghwi Park
Journal:  Dysphagia       Date:  2021-01-02       Impact factor: 3.438

3.  Neuromuscular electrical stimulation versus traditional therapy in patients with Parkinson's disease and oropharyngeal dysphagia: effects on quality of life.

Authors:  B J Heijnen; R Speyer; L W J Baijens; H C A Bogaardt
Journal:  Dysphagia       Date:  2011-11-13       Impact factor: 3.438

4.  The effect of surface electrical stimulation on swallowing in dysphagic Parkinson patients.

Authors:  Laura W J Baijens; Renée Speyer; Valeria Lima Passos; Walmari Pilz; Nel Roodenburg; Père Clavé
Journal:  Dysphagia       Date:  2012-01-12       Impact factor: 3.438

5.  Swallowing in Parkinson Patients versus Healthy Controls: Reliability of Measurements in Videofluoroscopy.

Authors:  Laura W J Baijens; Renée Speyer; Valéria Lima Passos; Walmari Pilz; Nel Roodenburg; Pere Clave
Journal:  Gastroenterol Res Pract       Date:  2011-10-03       Impact factor: 2.260

6.  Identifying Patterns of FEES-Derived Swallowing Trajectories Using Group-Based Trajectory Model.

Authors:  Laura W J Baijens; Walmari Pilz; Bernd Kremer; Valeria Lima Passos
Journal:  Dysphagia       Date:  2015-07-25       Impact factor: 3.438

7.  Swallowing Assessment in Parkinson's Disease: Patient and Investigator Reported Outcome Measures are not Aligned.

Authors:  M R A van Hooren; R Vos; M G M H Florie; W Pilz; B Kremer; L W J Baijens
Journal:  Dysphagia       Date:  2020-10-31       Impact factor: 3.438

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.